Molecular subtyping of breast cancer improves identification of both high and low risk patients.

Maria RossingOlga ØstrupWiktor W MajewskiSavvas KinalisMaj-Britt JensenAnn KnoopNiels KromanMaj-Lis TalmanThomas V O HansenBent EjlertsenFinn C Nielsen

Published in: Acta oncologica (Stockholm, Sweden) (2017)

Transcriptome based subtyping of breast tumors evidently reduces the need for adjuvant chemotherapy and improves identification of women with predisposing mutations. The results imply that transcriptome profiling should become an integrated part of current breast cancer management.

Keyphrases

single cell
end stage renal disease
rna seq
gene expression
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
bioinformatics analysis